Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
Albani
C
C
Department of Neurology, University Hospital Zürich, Switzerland.
Buck
A
A
D000328:Adult; D001479:Basal Ganglia / Q000187:drug effects / Q000503:physiopathology; D001545:Benserazide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology; D009127:Muscle Rigidity / Q000188:drug therapy / Q000503:physiopathology; D009460:Neurologic Examination / Q000187:drug effects / Q000295:instrumentation*; D009949:Orientation / Q000187:drug effects / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011597:Psychomotor Performance / Q000187:drug effects* / Q000502:physiology; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation*; D014202:Tremor / Q000188:drug therapy / Q000503:physiopathology
D004338:Drug Combinations; D007980:Levodopa; D001545:Benserazide